At the 3rd annual School of Oncology Nursing Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, presented on supportive care for GU malignancies and we had the chance to discuss the highlights with her.
At the 3rd annual School of Oncology Nursing, Oncology Nursing News® had the chance to sit down with Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, and discuss her presentation on GU malignancies highlighting one of the most important takeaways from the presentation.
So as far as a presentation on GU malignancies and supportive care, I think it's important for nurses to take home the awareness that bone metastasis is a challenge, it does occur, and we need to make sure we assess and intervene early in order to minimize the negative impact it has on a patient. If we can control their systemic disease, the challenge is bones and brain are oftentimes more sanctuary sights and may not have the same benefit from therapy. So, we need to be astute in our assessment and awareness of these potential sites for metastasis and make sure we're intervening early because there are definitely advances in the options to treat those problems.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.